Your browser doesn't support javascript.
loading
SACCSG HL-2018. Barriers and enablers of a harmonized treatment protocol for childhood and adolescent Hodgkin lymphoma in South Africa.
Geel, Jennifer; Hendricks, Marc; Goga, Yasmin; Neethling, Beverley; Netshituni, Vutshilo; Mathew, Rema; Vermeulen, Johani; van Zyl, Anel; Omar, Fareed; du Plessis, Jan; du Plessis, Liezl; Madzhia, Elelwani; Ngcana, Thandeka; Naidoo, Thanushree; Louw, Lizette; Ballot, Daynia E; Metzger, Monika L.
Affiliation
  • Geel J; Pediatric Haematology-Oncology, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
  • Hendricks M; Pediatric Haematology-Oncology, University of Cape Town, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
  • Goga Y; Pediatric Haematology-Oncology, University of KwaZulu-Natal, Inkosi Albert Luthuli Hospital, Durban, South Africa.
  • Neethling B; Pediatric Haematology-Oncology, University of KwaZulu-Natal, Durban, Inkosi Albert Luthuli Hospital and Greys Hospital, Pietermaritzburg, South Africa.
  • Netshituni V; Pediatric Haematology-Oncology, University of Limpopo, Polokwane-Mankweng Hospital Complex, Polokwane, South Africa.
  • Mathew R; Pediatric Haematology-Oncology, Walter Sisulu University, Frere Hospital, East London, South Africa.
  • Vermeulen J; Pediatric Haematology-Oncology, Walter Sisulu University, Dora Nginza Hospital, Qheberha, South Africa.
  • van Zyl A; Pediatric Haematology-Oncology, University of Stellenbosch, Tygerberg Hospital, Cape Town, South Africa.
  • Omar F; Pediatric Haematology-Oncology, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa.
  • du Plessis J; Pediatric Haematology-Oncology, University of the Free State, Universitas Hospital, Bloemfontein, South Africa.
  • du Plessis L; Pediatric Haematology-Oncology, University of the Free State, Kimberley Hospital, Kimberley, South Africa.
  • Madzhia E; Pediatric Haematology-Oncology, Sefako Makgatho University, Dr George Mukhari Hospital, Garankuwa, South Africa.
  • Ngcana T; Pediatric Haematology-Oncology, University of the Witwatersrand, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
  • Naidoo T; Department of Radiation Oncology, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
  • Louw L; Department of Nuclear Medicine, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
  • Ballot DE; School of Clinical Medicine, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
  • Metzger ML; Medecins sans Frontieres, Democratic Republic of the Congo.
Pediatr Hematol Oncol ; 40(3): 300-313, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36661569
ABSTRACT

Introduction:

Collaborative studies have contributed to improved survival of pediatric Hodgkin lymphoma in well-resourced settings, but few are documented in resource-constrained countries. The South Africa Children's Cancer Study Group initiated harmonization of management protocols in 2015. This article analyzes barriers and enablers of the process.

Methods:

Clinician-researchers at 11 state-funded pediatric oncology units completed preparatory questionnaires in June 2018. Parameters included infrastructure, access to therapeutic modalities and clinician numbers. A reassessment of 13 sites (two new pediatric oncology unit) in February 2021 ascertained changes in resources and identified challenges to full participation. Questions investigated the presence and quality of diagnostic radiology, availability of surgeons, cytology/pathology options and hematology laboratory facilities.

Results:

The response rate was 11/11 to survey 1 and 13/13 to survey 2. The anticipated pre-study barriers to participation of pediatric oncology units included time constraints and understaffing. PET-CT was unavailable to two centers. The majority of pediatric oncology units met the minimum criteria to participate. The interim survey confirmed chemotherapy and radiotherapy availability nearly 100% of the time. One site reported improved access to radiotherapy while another reported improved access to PET-CT. Barriers to participation included excessive times to obtain regulatory approvals, time constraints and lack of dedicated research staff. Enablers include the simple management algorithm and communication tools.

Conclusion:

This study demonstrates that multicenter collaboration and harmonization of management protocols are achievable in a middle-income setting. Minimal funding is required but full participation to run high-quality studies requires more financial investment. Focused funding and increased prioritization of research may address systemic barriers to full participation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Child / Humans Country/Region as subject: Africa Language: En Journal: Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Child / Humans Country/Region as subject: Africa Language: En Journal: Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2023 Document type: Article Affiliation country: